AFFINERGY, LLC
Morrisville, NC, 27560-6363
DUNS: 078296854
# of Employees: 27
HUBZone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Award Charts
Award Listing
-
Record 1 TO 59
-
Peptide based tool for the rapid isolation of quiescent monocytes from peripheral blood
Amount: $308,839.00SUMMARY ABSTRACT Dendritic cell DC therapy represents a new and promising immunotherapeutic approach for treatment of advanced stage cancers with DC vaccines already approved for use in advanced pr ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Novel PhageLock assay to measure hepcidin for clinical monitoring
Amount: $333,003.00SUMMARY ABSTRACT Hepcidin is the peptide hormone responsible for regulating circulating iron concentrations Overexpression of hepcidin results in severe iron deficiency and anemia whereas hepcidin d ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Stem cell binding peptides for rapid fixation of total hip replacements
Amount: $749,918.00SUMMARY ABSTRACT Through modern surgical advancements total hip replacements THR have become one of the most successful implant procedures to date Even though long term success rates are high th ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Point of care device to identify patients at risk for preeclampsia
Amount: $200,000.00SUMMARY ABSTRACT Preeclampsia is a complication of pregnancy characterized by elevated blood pressure proteinuria and endothelial dysfunction involving multiple organ systems Worldwide preeclampsi ...
SBIRPhase I2017Department of Health and Human Services -
Novel technologies for detection of podocytes from preeclamptic patients
Amount: $707,804.00Preeclampsia is a complication of pregnancy characterized by elevated blood pressure proteinuria and endothelial dysfunction involving multiple organ systems Worldwide preeclampsia is the largest ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Novel technologies for improved slide quality of pancreatic fine-needle aspirates
Amount: $301,009.00DESCRIPTION provided by applicant Endoscopic ultrasound guided fine needle aspiration biopsy is the standard technique for diagnosis and staging of suspicious pancreatic lesions Unfortunately blo ...
SBIRPhase I2016Department of Health and Human Services -
Peptide-based slides for improving the diagnostic quality of sputum specimens
Amount: $299,999.00SUMMARY ABSTRACT Lung cancer is the leading cause of cancer related mortality in both men and women in United States with a dismal year survival rate of While surgery is the only curative optio ...
SBIRPhase I2016Department of Health and Human Services -
Novel technologies for the detection of podocytes from preeclamptic patients
Amount: $299,999.00SUMMARY ABSTRACT Preeclampsia is a complication of pregnancy characterized by elevated blood pressure proteinuria and endothelial dysfunction involving multiple organ systems Worldwide preeclampsi ...
SBIRPhase I2016Department of Health and Human Services -
Phage based assay to measure daptomycin concentration in biological fluids
Amount: $1,340,208.00DESCRIPTION provided by applicant Severe Gram positive infections are difficult to treat and associated with high mortality in hospital settings Daptomycin is a broad spectrum antibiotic that has ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Beta-2 Microglobulin Depletion Columns for Amyloidosis Prevention and Treatment
Amount: $293,816.00DESCRIPTION provided by applicant Approximately Americans undergo regular dialysis treatment because of complete kidney failure otherwise known as end stage renal disease ESRD The numbe ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health
